APO Research
Talk to an analyst

APO RESEARCH · REPORT

Ventricular Assist Device

Ventricular assist devices are mechanical pumps used to support cardiac circulation in patients who have weakened hearts.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Ventricular assist devices are mechanical pumps used to support cardiac circulation in patients who have weakened hearts.

A ventricular assist device (VAD) is an electromechanical device for assisting cardiac circulation, which is used either to partially or to completely replace the function of a failing heart. The function of VADs is different from that of artificial cardiac pacemakers; some are for short-term use, typically for patients recovering from myocardial infarction (heart attack) and for patients recovering from cardiac surgery; some are for long-term use (months to years to perpetuity), typically for patients suffering from advanced heart failure.

Selected research

Market Outlook & Growth Opportunities

Global Ventricular Assist Device Market Outlook and Growth Opportunities 2026

20 December 2025195 pages

Choose your research edition.

Industry ResearchVentricular Assist Device Industry Research Report 2026105 pages · $2,950 USDIndustry Growth & TrendsGlobal Ventricular Assist Device Industry Growth and Trends Forecast to 203276 pages · $3,450 USDMarket StructureGlobal Ventricular Assist Device Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032177 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Ventricular Assist Device Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Ventricular Assist Device Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

Ventricular assist devices are mechanical pumps used to support cardiac circulation in patients who have weakened hearts.

A ventricular assist device (VAD) is an electromechanical device for assisting cardiac circulation, which is used either to partially or to completely replace the function of a failing heart. The function of VADs is different from that of artificial cardiac pacemakers; some are for short-term use, typically for patients recovering from myocardial infarction (heart attack) and for patients recovering from cardiac surgery; some are for long-term use (months to years to perpetuity), typically for patients suffering from advanced heart failure.

In United States, Ventricular Assist Device key players include AbioMed, Abbott (Thoratec), Medtronic (HeartWare), etc. United States top five manufacturers hold a share over 95%.

Read the full market overview

In terms of product, LVADs is the largest segment, with a share about 90%. And in terms of application, the largest application is Bridge-to-transplant (BTT) , followed by Destination Therapy (DT).

This report provides an overview of the global Ventricular Assist Device market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Ventricular Assist Device and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Ventricular Assist Device sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Ventricular Assist Device market size, projected growth trends, production technologies, key applications, and end-use industries.

Ventricular Assist Device Segment by Company

AbioMed

Abbott (Thoratec)

Medtronic (HeartWare)

Berlin Heart

Ventricular Assist Device Segment by Type

LVADs

RVADs

BIVADs

Ventricular Assist Device Segment by Application

Bridge-to-transplant (BTT)

Destination Therapy (DT)

Other

Ventricular Assist Device Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Ventricular Assist Device status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Ventricular Assist Device market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Ventricular Assist Device significant trends, drivers, influence factors in global and regions.

6. To analyze Ventricular Assist Device competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ventricular Assist Device market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Ventricular Assist Device and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ventricular Assist Device.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Ventricular Assist Device market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Ventricular Assist Device industry.

Chapter 3: Detailed analysis of Ventricular Assist Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Ventricular Assist Device in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Ventricular Assist Device in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Ventricular Assist Device Industry Trends Table 2. Ventricular Assist Device Industry Drivers Table 3. Ventricular Assist Device Industry Opportunities and Challenges Table 4. Ventricular Assist Device Industry Restraints Table 5. Global Ventricular Assist Device Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Ventricular Assist Device Revenue Share by Company (2021-2026) Table 7. Global Ventricular Assist Device Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Ventricular Assist Device Sales Volume Share by Company (2021-2026) Table 9. Global Ventricular Assist Device Average Price (K USD/Unit) of Company (2021-2026) Table 10. Global Ventricular Assist Device Company Ranking, (2024-2026) & (USD Million) Table 11. Global Ventricular Assist Device Key Company Manufacturing Base & Headquarters Table 12. Global Ventricular Assist Device Company, Product Type & Application Table 13. Global Ventricular Assist Device Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Ventricular Assist Device by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of LVADs Table 18. Significant Companies of RVADs Table 19. Significant Companies of BIVADs Table 20. Global Ventricular Assist Device Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Ventricular Assist Device Sales Volume by Type (2021-2026) & (K Units) Table 22. Global Ventricular Assist Device Sales Volume by Type (2027-2032) & (K Units) Table 23. Global Ventricular Assist Device Sales Volume Share by Type (2021-2026) Table 24. Global Ventricular Assist Device Sales Volume Share by Type (2027-2032) Table 25. Global Ventricular Assist Device Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Ventricular Assist Device Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Ventricular Assist Device Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Ventricular Assist Device Sales Value Share by Type (2021-2026) Table 29. Global Ventricular Assist Device Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Bridge-to-transplant (BTT) Table 31. Significant Companies of Destination Therapy (DT) Table 32. Significant Companies of Other Table 33. Global Ventricular Assist Device Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Ventricular Assist Device Sales Volume by Application (2021-2026) & (K Units) Table 35. Global Ventricular Assist Device Sales Volume by Application (2027-2032) & (K Units) Table 36. Global Ventricular Assist Device Sales Volume Share by Application (2021-2026) Table 37. Global Ventricular Assist Device Sales Volume Share by Application (2027-2032) Table 38. Global Ventricular Assist Device Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Ventricular Assist Device Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Ventricular Assist Device Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Ventricular Assist Device Sales Value Share by Application (2021-2026) Table 42. Global Ventricular Assist Device Sales Value Share by Application (2027-2032) Table 43. Global Ventricular Assist Device Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Ventricular Assist Device Sales by Region (2021-2026) & (K Units) Table 45. Global Ventricular Assist Device Sales Market Share by Region (2021-2026) Table 46. Global Ventricular Assist Device Sales by Region (2027-2032) & (K Units) Table 47. Global Ventricular Assist Device Sales Market Share by Region (2027-2032) Table 48. Global Ventricular Assist Device Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Ventricular Assist Device Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Ventricular Assist Device Sales Value Share by Region (2021-2026) Table 51. Global Ventricular Assist Device Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Ventricular Assist Device Sales Value Share by Region (2027-2032) Table 53. Global Ventricular Assist Device Market Average Price (K USD/Unit) by Region (2021-2026) Table 54. Global Ventricular Assist Device Market Average Price (K USD/Unit) by Region (2027-2032) Table 55. Global Ventricular Assist Device Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. Global Ventricular Assist Device Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Ventricular Assist Device Sales by Country (2021-2026) & (K Units) Table 58. Global Ventricular Assist Device Sales Market Share by Country (2021-2026) Table 59. Global Ventricular Assist Device Sales by Country (2027-2032) & (K Units) Table 60. Global Ventricular Assist Device Sales Market Share by Country (2027-2032) Table 61. Global Ventricular Assist Device Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Ventricular Assist Device Sales Value Market Share by Country (2021-2026) Table 63. Global Ventricular Assist Device Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Ventricular Assist Device Sales Value Market Share by Country (2027-2032) Table 65. AbioMed Company Information Table 66. AbioMed Business Overview Table 67. AbioMed Ventricular Assist Device Sales (K Units), Value (US$ Million), Price (K USD/Unit) and Gross Margin (2021-2026) Table 68. AbioMed Ventricular Assist Device Product Portfolio Table 69. AbioMed Recent Development Table 70. Abbott (Thoratec) Company Information Table 71. Abbott (Thoratec) Business Overview Table 72. Abbott (Thoratec) Ventricular Assist Device Sales (K Units), Value (US$ Million), Price (K USD/Unit) and Gross Margin (2021-2026) Table 73. Abbott (Thoratec) Ventricular Assist Device Product Portfolio Table 74. Abbott (Thoratec) Recent Development Table 75. Medtronic (HeartWare) Company Information Table 76. Medtronic (HeartWare) Business Overview Table 77. Medtronic (HeartWare) Ventricular Assist Device Sales (K Units), Value (US$ Million), Price (K USD/Unit) and Gross Margin (2021-2026) Table 78. Medtronic (HeartWare) Ventricular Assist Device Product Portfolio Table 79. Medtronic (HeartWare) Recent Development Table 80. Berlin Heart Company Information Table 81. Berlin Heart Business Overview Table 82. Berlin Heart Ventricular Assist Device Sales (K Units), Value (US$ Million), Price (K USD/Unit) and Gross Margin (2021-2026) Table 83. Berlin Heart Ventricular Assist Device Product Portfolio Table 84. Berlin Heart Recent Development Table 85. Key Raw Materials Table 86. Raw Materials Key Suppliers Table 87. Ventricular Assist Device Distributors List Table 88. Ventricular Assist Device Customers List Table 89. Research Programs/Design for This Report Table 90. Authors List of This Report Table 91. Secondary Sources Table 92. Primary Sources List of Figures Figure 1. Ventricular Assist Device Product Image Figure 2. Global Ventricular Assist Device Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Ventricular Assist Device Sales Value (2021-2032) & (US$ Million) Figure 4. Global Ventricular Assist Device Sales (2021-2032) & (K Units) Figure 5. Global Ventricular Assist Device Sales Average Price (K USD/Unit) & (2021-2032) Figure 6. Global Ventricular Assist Device Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. LVADs Image Figure 10. RVADs Image Figure 11. BIVADs Image Figure 12. Global Ventricular Assist Device Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Ventricular Assist Device Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Ventricular Assist Device Sales Volume Share by Type (2021-2032) Figure 15. Global Ventricular Assist Device Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Ventricular Assist Device Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Ventricular Assist Device Sales Value Share by Type (2021-2032) Figure 18. Bridge-to-transplant (BTT) Image Figure 19. Destination Therapy (DT) Image Figure 20. Other Image Figure 21. Global Ventricular Assist Device Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Ventricular Assist Device Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Ventricular Assist Device Sales Volume Share by Application (2021-2032) Figure 24. Global Ventricular Assist Device Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Ventricular Assist Device Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Ventricular Assist Device Sales Value Share by Application (2021-2032) Figure 27. Global Ventricular Assist Device Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 28. Global Ventricular Assist Device Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Ventricular Assist Device Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Ventricular Assist Device Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Ventricular Assist Device Sales Value (2021-2032) & (US$ Million) Figure 32. North America Ventricular Assist Device Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Ventricular Assist Device Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Ventricular Assist Device Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Ventricular Assist Device Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Ventricular Assist Device Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Ventricular Assist Device Sales Value (2021-2032) & (US$ Million) Figure 38. South America Ventricular Assist Device Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Ventricular Assist Device Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Ventricular Assist Device Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Ventricular Assist Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Ventricular Assist Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Ventricular Assist Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Ventricular Assist Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Ventricular Assist Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Ventricular Assist Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Ventricular Assist Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Ventricular Assist Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Ventricular Assist Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Ventricular Assist Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Ventricular Assist Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Ventricular Assist Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Ventricular Assist Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Ventricular Assist Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Ventricular Assist Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Ventricular Assist Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Ventricular Assist Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Ventricular Assist Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Ventricular Assist Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Ventricular Assist Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Ventricular Assist Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Ventricular Assist Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Ventricular Assist Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Ventricular Assist Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Ventricular Assist Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Ventricular Assist Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Ventricular Assist Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Ventricular Assist Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Ventricular Assist Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Ventricular Assist Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Ventricular Assist Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Ventricular Assist Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Ventricular Assist Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Ventricular Assist Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Ventricular Assist Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Ventricular Assist Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Ventricular Assist Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Ventricular Assist Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Ventricular Assist Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Ventricular Assist Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Ventricular Assist Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Ventricular Assist Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Ventricular Assist Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Ventricular Assist Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Ventricular Assist Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Ventricular Assist Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Ventricular Assist Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Ventricular Assist Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Ventricular Assist Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Ventricular Assist Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Ventricular Assist Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Ventricular Assist Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Ventricular Assist Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Ventricular Assist Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Ventricular Assist Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Ventricular Assist Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Ventricular Assist Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Ventricular Assist Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Ventricular Assist Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Ventricular Assist Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Ventricular Assist Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Ventricular Assist Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Ventricular Assist Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Ventricular Assist Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Ventricular Assist Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Ventricular Assist Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Ventricular Assist Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Ventricular Assist Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Ventricular Assist Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Ventricular Assist Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Ventricular Assist Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Ventricular Assist Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Ventricular Assist Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Ventricular Assist Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Ventricular Assist Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Ventricular Assist Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Ventricular Assist Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Ventricular Assist Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Ventricular Assist Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Ventricular Assist Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Ventricular Assist Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Ventricular Assist Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Ventricular Assist Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Ventricular Assist Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Ventricular Assist Device Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Ventricular Assist Device Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • LVADs
  • RVADs
  • BIVADs
Applications
  • Bridge-to-transplant (BTT)
  • Destination Therapy (DT)
  • Other
Companies covered
  • AbioMed
  • Abbott (Thoratec)
  • Medtronic (HeartWare)
  • Berlin Heart

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Ventricular Assist Device Sales Value (2021-2032)
  4. 1.2.2 Global Ventricular Assist Device Sales Volume (2021-2032)
  5. 1.2.3 Global Ventricular Assist Device Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Ventricular Assist Device Market Dynamics
  1. 2.1 Ventricular Assist Device Industry Trends
  2. 2.2 Ventricular Assist Device Industry Drivers
  3. 2.3 Ventricular Assist Device Industry Opportunities and Challenges
  4. 2.4 Ventricular Assist Device Industry Restraints
3 Ventricular Assist Device Market by Company
  1. 3.1 Global Ventricular Assist Device Company Revenue Ranking in 2025
  2. 3.2 Global Ventricular Assist Device Revenue by Company (2021-2026)
  3. 3.3 Global Ventricular Assist Device Sales Volume by Company (2021-2026)
  4. 3.4 Global Ventricular Assist Device Average Price by Company (2021-2026)
  5. 3.5 Global Ventricular Assist Device Company Ranking (2024-2026)
  6. 3.6 Global Ventricular Assist Device Company Manufacturing Base and Headquarters
  7. 3.7 Global Ventricular Assist Device Company Product Type and Application
  8. 3.8 Global Ventricular Assist Device Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Ventricular Assist Device Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Ventricular Assist Device Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Ventricular Assist Device Market by Type
  1. 4.1 Ventricular Assist Device Type Introduction
  2. 4.1.1 LVADs
  3. 4.1.2 RVADs
  4. 4.1.3 BIVADs
  5. 4.2 Global Ventricular Assist Device Sales Volume by Type
  6. 4.2.1 Global Ventricular Assist Device Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Ventricular Assist Device Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Ventricular Assist Device Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Ventricular Assist Device Sales Value by Type
  10. 4.3.1 Global Ventricular Assist Device Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Ventricular Assist Device Sales Value by Type (2021-2032)
  12. 4.3.3 Global Ventricular Assist Device Sales Value Share by Type (2021-2032)
5 Ventricular Assist Device Market by Application
  1. 5.1 Ventricular Assist Device Application Introduction
  2. 5.1.1 Bridge-to-transplant (BTT)
  3. 5.1.2 Destination Therapy (DT)
  4. 5.1.3 Other
  5. 5.2 Global Ventricular Assist Device Sales Volume by Application
  6. 5.2.1 Global Ventricular Assist Device Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Ventricular Assist Device Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Ventricular Assist Device Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Ventricular Assist Device Sales Value by Application
  10. 5.3.1 Global Ventricular Assist Device Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Ventricular Assist Device Sales Value by Application (2021-2032)
  12. 5.3.3 Global Ventricular Assist Device Sales Value Share by Application (2021-2032)
6 Ventricular Assist Device Regional Sales and Value Analysis
  1. 6.1 Global Ventricular Assist Device Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Ventricular Assist Device Sales by Region (2021-2032)
  3. 6.2.1 Global Ventricular Assist Device Sales by Region: 2021-2026
  4. 6.2.2 Global Ventricular Assist Device Sales by Region (2027-2032)
  5. 6.3 Global Ventricular Assist Device Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Ventricular Assist Device Sales Value by Region (2021-2032)
  7. 6.4.1 Global Ventricular Assist Device Sales Value by Region: 2021-2026
  8. 6.4.2 Global Ventricular Assist Device Sales Value by Region (2027-2032)
  9. 6.5 Global Ventricular Assist Device Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Ventricular Assist Device Sales Value (2021-2032)
  12. 6.6.2 North America Ventricular Assist Device Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Ventricular Assist Device Sales Value (2021-2032)
  15. 6.7.2 Europe Ventricular Assist Device Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Ventricular Assist Device Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Ventricular Assist Device Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Ventricular Assist Device Sales Value (2021-2032)
  21. 6.9.2 South America Ventricular Assist Device Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Ventricular Assist Device Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Ventricular Assist Device Sales Value Share by Country, 2025 VS 2032
7 Ventricular Assist Device Country-level Sales and Value Analysis
  1. 7.1 Global Ventricular Assist Device Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Ventricular Assist Device Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Ventricular Assist Device Sales by Country (2021-2032)
  4. 7.3.1 Global Ventricular Assist Device Sales by Country (2021-2026)
  5. 7.3.2 Global Ventricular Assist Device Sales by Country (2027-2032)
  6. 7.4 Global Ventricular Assist Device Sales Value by Country (2021-2032)
  7. 7.4.1 Global Ventricular Assist Device Sales Value by Country (2021-2026)
  8. 7.4.2 Global Ventricular Assist Device Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Ventricular Assist Device Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Ventricular Assist Device Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Ventricular Assist Device Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Ventricular Assist Device Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Ventricular Assist Device Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Ventricular Assist Device Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Ventricular Assist Device Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Ventricular Assist Device Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Ventricular Assist Device Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Ventricular Assist Device Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Ventricular Assist Device Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Ventricular Assist Device Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Ventricular Assist Device Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Ventricular Assist Device Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Ventricular Assist Device Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Ventricular Assist Device Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Ventricular Assist Device Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Ventricular Assist Device Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Ventricular Assist Device Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Ventricular Assist Device Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Ventricular Assist Device Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Ventricular Assist Device Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Ventricular Assist Device Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Ventricular Assist Device Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Ventricular Assist Device Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Ventricular Assist Device Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Ventricular Assist Device Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Ventricular Assist Device Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Ventricular Assist Device Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Ventricular Assist Device Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Ventricular Assist Device Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Ventricular Assist Device Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Ventricular Assist Device Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Ventricular Assist Device Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Ventricular Assist Device Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Ventricular Assist Device Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Ventricular Assist Device Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Ventricular Assist Device Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Ventricular Assist Device Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Ventricular Assist Device Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Ventricular Assist Device Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Ventricular Assist Device Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Ventricular Assist Device Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Ventricular Assist Device Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Ventricular Assist Device Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Ventricular Assist Device Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Ventricular Assist Device Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Ventricular Assist Device Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Ventricular Assist Device Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Ventricular Assist Device Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Ventricular Assist Device Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Ventricular Assist Device Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Ventricular Assist Device Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Ventricular Assist Device Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Ventricular Assist Device Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Ventricular Assist Device Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Ventricular Assist Device Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Ventricular Assist Device Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Ventricular Assist Device Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Ventricular Assist Device Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Ventricular Assist Device Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Ventricular Assist Device Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Ventricular Assist Device Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Ventricular Assist Device Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Ventricular Assist Device Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Ventricular Assist Device Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Ventricular Assist Device Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Ventricular Assist Device Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Ventricular Assist Device Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Ventricular Assist Device Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Ventricular Assist Device Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Ventricular Assist Device Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Ventricular Assist Device Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Ventricular Assist Device Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Ventricular Assist Device Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Ventricular Assist Device Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Ventricular Assist Device Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Ventricular Assist Device Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Ventricular Assist Device Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Ventricular Assist Device Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Ventricular Assist Device Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Ventricular Assist Device Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Ventricular Assist Device Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Ventricular Assist Device Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 AbioMed
  2. 8.1.1 AbioMed Company Information
  3. 8.1.2 AbioMed Business Overview
  4. 8.1.3 AbioMed Ventricular Assist Device Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 AbioMed Ventricular Assist Device Product Portfolio
  6. 8.1.5 AbioMed Recent Developments
  7. 8.2 Abbott (Thoratec)
  8. 8.2.1 Abbott (Thoratec) Company Information
  9. 8.2.2 Abbott (Thoratec) Business Overview
  10. 8.2.3 Abbott (Thoratec) Ventricular Assist Device Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Abbott (Thoratec) Ventricular Assist Device Product Portfolio
  12. 8.2.5 Abbott (Thoratec) Recent Developments
  13. 8.3 Medtronic (HeartWare)
  14. 8.3.1 Medtronic (HeartWare) Company Information
  15. 8.3.2 Medtronic (HeartWare) Business Overview
  16. 8.3.3 Medtronic (HeartWare) Ventricular Assist Device Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Medtronic (HeartWare) Ventricular Assist Device Product Portfolio
  18. 8.3.5 Medtronic (HeartWare) Recent Developments
  19. 8.4 Berlin Heart
  20. 8.4.1 Berlin Heart Company Information
  21. 8.4.2 Berlin Heart Business Overview
  22. 8.4.3 Berlin Heart Ventricular Assist Device Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Berlin Heart Ventricular Assist Device Product Portfolio
  24. 8.4.5 Berlin Heart Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Ventricular Assist Device Value Chain Analysis
  2. 9.1.1 Ventricular Assist Device Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Ventricular Assist Device Sales Mode & Process
  6. 9.2 Ventricular Assist Device Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Ventricular Assist Device Distributors
  9. 9.2.3 Ventricular Assist Device Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst